Encyklopedi

Biomarkörer

Measurable indicators of biological age, health span, and metabolic status.

27 biomarkers +2 in 2d +2 this week Live: new data today
biomarker1

25-Hydroxyvitamin D (Vitamin D Status)

The standard blood test for vitamin D status; correcting deficiency matters for bone health, but large RCTs have not confirmed broader cancer or cardiovascular prevention claims.

2026-08Read →
biomarker2

Apolipoprotein B (ApoB)

The structural protein on every atherogenic lipoprotein particle, directly counting cardiovascular risk-carrying particles better than LDL cholesterol alone.

2026-08Read →
biomarker2

Body Composition (Fat Mass, Lean Mass, Visceral Fat)

The muscle-to-fat and fat-distribution profile of the body, where the combination of low muscle mass and high visceral fat (sarcopenic obesity) carries dramatically higher mortality risk than either alone.

2026-08Read →
biomarker3

Carotid Intima-Media Thickness (IMT)

An ultrasound measurement of carotid artery wall thickness used as a marker of subclinical atherosclerosis, though its added predictive value over standard risk calculators is modest.

2026-08Read →
biomarker2

Coronary Artery Calcium (CAC) Poäng

A CT scan measurement of calcified coronary plaque that directly images atherosclerosis and meaningfully reclassifies cardiovascular risk beyond standard risk calculators.

2026-08Read →
biomarker2

DunedinPACE (Pace of Aging Clock)

A DNA methylation measure of the current rate of biological aging, built from 19 organ-system biomarkers tracked longitudinally in the Dunedin birth cohort.

2026-08Read →
biomarker2

Frailty Index

A overall score counting accumulated health deficits across many domains that predicts mortality more accurately than any single biomarker in the oldest-old.

2026-08Read →
biomarker2

Gait Speed

A simple timed walking-speed test in older adults that predicts survival about as accurately as detailed clinical risk models combining multiple disease and lifestyle factors.

2026-08Read →
biomarker4

GlycanAge (IgG Glycosylation Age)

A commercial biological-age test based on antibody sugar-chain patterns reflecting immune inflammatory aging, with a thinner independent evidence base than established epigenetic clocks.

2026-08Read →
biomarker2

GrimAge (DNAm GrimAge Epigenetic Clock)

A second-generation epigenetic clock trained directly on mortality data that outperforms earlier clocks at predicting death, heart disease, and cancer risk in cohort studies.

2026-08Read →
biomarker2

Grip Strength

A simple handheld dynamometer test that predicts all-cause mortality and cardiovascular events more strongly than systolic blood pressure in large cohort studies.

2026-08Read →
biomarker3

HDL Cholesterol (HDL-C)

Cholesterol carried by high-density lipoprotein particles, historically called protective, but pharmaceutical trials raising it have repeatedly failed to reduce cardiovascular events.

2026-08Read →
biomarker2

HOMA-IR

A calculated index from fasting glucose and insulin that estimates insulin resistance, the metabolic driver behind type 2 diabetes and a core aging-related biomarker.

2026-08Read →
biomarker2

HbA1c (Glycated Hemoglobin)

A blood test reflecting average glucose exposure over 2-3 months, used to diagnose diabetes and track long-term glycemic control.

2026-08Read →
biomarker2

Heart Rate Variability (HRV)

The beat-to-beat variation in heart timing reflecting autonomic nervous system balance; lower HRV consistently predicts higher mortality across general and cardiovascular disease populations.

2026-08Read →
biomarker3

Homocysteine

An amino acid byproduct linked to cardiovascular and cognitive risk in observational studies, but B-vitamin trials lowering it have not reduced heart attacks or strokes.

2026-08Read →
biomarker2

Horvath Clock (DNA Methylation Age)

The first widely used epigenetic clock estimates biological age from DNA methylation patterns and predicts mortality risk independent of chronological age.

2026-08Read →
biomarker2

Interleukin-6 (IL-6)

A key inflammaging cytokine whose chronic elevation independently and consistently predicts mortality across multiple large cohorts of older adults.

2026-08Read →
biomarker1

LDL Cholesterol (LDL-C)

The cholesterol carried by low-density lipoprotein particles, a well-established causal driver of atherosclerotic cardiovascular disease.

2026-08Read →
biomarker3

NAD+ (Blood/Tissue Levels)

A cellular energy coenzyme that declines with age in multiple tissues; NR and NMN reliably raise blood NAD+ levels, but functional or lifespan benefits remain unproven in large human trials.

2026-08Read →
biomarker2

Omega-3 Index

The percentage of EPA and DHA in red blood cell membranes, a stable biomarker of long-term omega-3 status linked to cardiovascular risk.

2026-08Read →
biomarker2

PhenoAge (DNAm PhenoAge Epigenetic Clock)

A second-generation epigenetic clock built from nine clinical mortality markers that predicts all-cause mortality, cancer, cardiovascular disease, and Alzheimer's risk in cohort studies.

2026-08Read →
biomarker2

Resting Heart Rate (RHR)

The number of heartbeats per minute at rest; higher values and rising trends over time both independently predict greater mortality risk across decades of Framingham and related cohort data.

2026-08Read →
biomarker2

Telomere Length (Leukocyte)

A modest, consistent predictor of mortality across large pooled cohorts, but with an effect size much smaller than established risk factors and no proven intervention to lengthen it.

2026-08Read →
biomarker3

Tumor Necrosis Factor-alpha (TNF-alpha)

A pro-inflammatory cytokine with mortality associations that shift meaningfully by sex and age, dominant in centenarian cohorts but less consistent than IL-6 in younger-old adults.

2026-08Read →
biomarker2

VO2max (Maximal Oxygen Uptake)

The gold-standard measure of cardiorespiratory fitness; higher VO2max predicts dramatically lower all-cause mortality with no evidence of harm even at extremely high fitness levels.

2026-08Read →
biomarker2

hs-CRP (High-Sensitivity C-Reactive Protein)

A sensitive blood marker of low-grade systemic inflammation that independently predicts cardiovascular events and all-cause mortality.

2026-08Read →